September 14th 2025
Optain Health secures $26 million in Series A funding to enhance AI-driven retinal disease detection and expand its technology.
September 11th 2025
Peter J. McDonnell, MD, and Neda Shamie, MD, consider the transformative landscape of cataract surgery, highlighting the impact of small-aperture IOL technology. The conversation delves into its potential benefits, influence on the market, and the evolving role of cataract surgeons in guiding patients through advanced options.
Read More
CU researcher receives grant to study Parkinson's disease biomarkers
November 11th 2023Jayashree Kalpathy-Cramer, PhD, was granted $300,000 from the Michael J Fox Foundation to examine key data put together at the Sue Anschutz-Rodgers Eye Center with artificial intelligence in an effort to identify biomarkers of Parkinson’s disease.
Read More
AAO 2023: Bausch + Lomb vice president gives update on 3 new technologies
November 7th 2023Anthony Wallace, BS, MBA, vice president and general manager of the surgical business at Bausch + Lomb North America spoke with Ophthalmology Times about 3 new technologies the company launched at this year's American Academy of Ophthalmology meeting.
Watch
AAO 2023: FundamentalVR and AAO team up for pediatric ophthalmic training VR program
November 3rd 2023The collaboration, fueled by a $5 million donation from Knights Templar Eye Foundation (KTEF), will introduce a free and open VR simulation program for ophthalmologists and trainees worldwide.
Read More
FDA grants Toku Breakthrough Device status for its cardiovascular risk AI platform
November 2nd 2023The company’s AI CLAIR technology platform has received FDA breakthrough device status, and if cleared by the FDA will deliver real-time cardiovascular disease risk assessments through routine eye exams.
Read More
ZEISS Medical Technology and Boehringer Ingelheim announce long-term collaboration
October 6th 2023The collaboration will drive an effort to develop predictive analytics to enable early detection of eye diseases and more personalized treatments to prevent vision loss for people with serious eye diseases.
Read More
Orbis celebrates 20 Years of Cybersight telemedicine platform, new app
September 5th 2023According to the company, the tool provides free access to training and mentors for eye care professionals in areas with the greatest need, and the new Cybersight mobile app expands access for eye care professionals through offline functionality.
Read More
UC Irvine researchers discover a nanobody which may lead to treatment for retinitis pigmentosa
September 1st 2023According to the university, a special antibody that is derived from llamas, called a nanobody, can stop the misfolding and the activation of Rhodopsin, a molecule whose mutations can lead to blindness.
Read More
Proceed with caution regarding AI-generated ophthalmic references and abstracts
August 19th 2023Clinicians should be alert to the fact that while artificial intelligence (AI) is capable of generating ideas and references, it is crucial to thoroughly vet and fact-check any medical research content that AI produces.
Read More